Data / Federal awards / NAICS 541714 / MINISTRY OF DEFENCE
MINISTRY OF DEFENCE: 8 federal contract awards, $11.2 million obligated (FY2024 to FY2027)
Updated October 6, 2026. Source: USAspending.gov.
MINISTRY OF DEFENCE (UEI U6LDUQKZ2CS8), Salisbury, United Kingdom, received 8 federal prime contract awards with $11.2 million obligated in fiscal years 2024 to 2027, from 2 agencies under 4 NAICS codes. Its largest buyer is Department of Defense ($11.3 million) and its largest code is NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The request: Every federal contract awarded under NAICS 541714, with the winner, the agency and the value. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.
- UEI
- U6LDUQKZ2CS8
- Location
- Salisbury, United Kingdom
- Business size
- Other Than Small Business
- Contract awards
- 8
- Obligated
- $11.2 million
- First action in window
- 2023-11-08
- Latest action
- 2026-07-21
Where the work is
NAICS codes, with the other winners in each.
| NAICS | Industry | Awards | Obligated |
|---|---|---|---|
| 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | 3 | $6.1 million |
| 541715 | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | 2 | $5.2 million |
| 325414 | Biological Product (except Diagnostic) Manufacturing | 1 | $0 |
| 541712 | Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) | 2 | $-122,877 |
Buying agencies
| Agency | Awards | Obligated |
|---|---|---|
| Department of Defense | 5 | $11.3 million |
| Department of Health and Human Services | 3 | $-87,430 |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2024 | $3.8 million |
| FY2025 | $2.9 million |
| FY2026 | $4.4 million |
Contract awards
All 8 awards in fiscal years 2024 to 2027.
| Award ID | Agency | Type | NAICS | What it buys | Obligated in window | Award value | Starts | Ends | Place of performance | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| HDTRA124C0008 | Department of Defense | Definitive Contract | 541714 | GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE. | $5,630,591 | $5,630,591 | June 10, 2024 | June 9, 2027 | United Kingdom | usaspending.gov |
| HDTRA122C0032 | Department of Defense | Definitive Contract | 541715 | NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS | $4,692,281 | $6,400,449 | September 28, 2022 | September 27, 2027 | United Kingdom | usaspending.gov |
| HDTRA122C0035 | Department of Defense | Definitive Contract | 541715 | FUNDAMENTAL RESEARCH OF A DEEP LEARNING DEVELOPMENT AND EVALUATION FRAMEWORK | $510,033 | $870,270 | September 30, 2022 | September 29, 2025 | United Kingdom | usaspending.gov |
| HDTRA120C0016 | Department of Defense | Definitive Contract | 541714 | PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY VIRAL ENCEPHALITIS | $494,818 | $1,189,719 | June 15, 2020 | June 14, 2025 | United Kingdom | usaspending.gov |
| 75N93024D00010 | Department of Health and Human Services | IDC | 541714 | PRE-CLINICAL MODELS OF INFECTIOUS DISEASES - TASK AREAS A AND B | $0 | $146,300,000 | July 15, 2024 | usaspending.gov | ||
| HHSO10033001T | Department of Health and Human Services | Delivery Order | 325414 | THIS TASK ORDER AWARDED TO THE DEFENCE SCIENCE AND TECHNOLOGY LABORATORY (DSTL), UK IS ISSUED TO CHARACTERIZE A NON-HUMAN PRIMATE MODEL TO I | $0 | $1,695,757 | September 7, 2012 | March 31, 2014 | United Kingdom | usaspending.gov |
| HDTRA117C0028 | Department of Defense | Definitive Contract | 541712 | CRYSTALCAST TOOLSET IGF::OT::IGF | $-35,447 | $3,922,194 | August 25, 2017 | August 24, 2021 | United Kingdom | usaspending.gov |
| HHSF223201510066C | Department of Health and Human Services | Definitive Contract | 541712 | IGF::CL::IGF BAA CONTRACT TITLED, "DETERMINATION OF THE EFFICACY OF ANTIBIOTICS AGAINST MELIOIDOSIS ACQUIRED BY DIFFERENT ROUTES OF INFECTIO | $-87,430 | $4,201,203 | August 4, 2015 | September 29, 2019 | United Kingdom | usaspending.gov |
Also on SpecStream
- All recipients under NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- All recipients under NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- All recipients under NAICS 325414 Biological Product (except Diagnostic) Manufacturing
- Open opportunities under NAICS 541714
- Open opportunities under NAICS 541715
- Open opportunities under NAICS 325414
Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.